Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:762-767
doi: 10.1161/hc3501.094232
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srámek, A.
Right arrow Articles by Rosendaal, F.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srámek, A.
Right arrow Articles by Rosendaal, F.R.
Related Collections
Right arrow Risk Factors
Right arrow Coagulation

(Circulation. 2001;104:762.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Decreased Coagulability Has No Clinically Relevant Effect on Atherogenesis

Observations in Individuals With a Hereditary Bleeding Tendency

A. Srámek, MD; J.H.C. Reiber, PhD; W.B.J. Gerrits, MD; F.R. Rosendaal, MD

From the Departments of Clinical Epidemiology (A.S., F.R.R.), and Radiology (J.H.C.R.) and the Hemostasis and Thrombosis Research Center (F.R.R.), Leiden University Medical Center, Leiden; and the Department of Hematology (W.B.J.G.), Leyenburg Hospital, The Hague, the Netherlands.

Correspondence to Prof Dr F.R. Rosendaal, Department of Clinical Epidemiology, CO-P46, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands. E-mail f.r.rosendaal{at}lumc.nl

Background— Hemostasis affects ischemic cardiovascular disease through its role in formation of occluding arterial thrombi. Several studies suggest that hemostasis also might play a role in atherogenesis. We investigated whether individuals with an inherited bleeding tendency are protected against development of atherosclerosis.

Methods and Results— A total of 76 individuals with an inherited bleeding tendency (hemophilia and von Willebrand disease) and 142 healthy controls were included in the present study. Early atherosclerotic vessel-wall changes were quantified by measurement of intima-media thickness in the carotid and femoral arteries by B-mode ultrasonography. To validate intima-media thickness measurements, measurements also were performed in 77 individuals with clinically proven atherosclerosis and in 34 healthy, age-matched controls. A large difference in intima-media thickness was found between individuals with proven atherosclerosis and healthy controls, in particular for the femoral artery (difference for carotid artery, 0.16 mm; femoral artery, 0.53 mm). Comparison between patients with a bleeding tendency and healthy controls showed only minimally reduced intima-media in femoral artery in individuals with a bleeding tendency (adjusted difference, -0.078 mm; 95% CI, -0.17 to 0.018 mm). Subgroup analysis revealed that in subjects with moderate to severe hemophilia, vessel walls were thinnest (adjusted difference, -0.10 mm; 95% CI, -0.27 to 0.061 mm).

Conclusions— Hypocoagulability caused by hemophilia or von Willebrand disease has at most a limited effect on atherogenesis.


Key Words: atherosclerosis • coagulation • carotid arteries • femoral arteries • ultrasonics




This article has been cited by other articles:


Home page
BloodHome page
O. Salomon, D. M. Steinberg, N. Koren-Morag, D. Tanne, and U. Seligsohn
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Blood, April 15, 2008; 111(8): 4113 - 4117.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Gailani and T. Renne
Intrinsic Pathway of Coagulation and Arterial Thrombosis
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2507 - 2513.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
F. Bilora, E. Zanon, A. Casonato, A. Bertomoro, F. Petrobelli, M. Cavraro, E. Campagnolo, and A. Girolami
Type IIB von Willebrand Disease: Role of Qualitative Defects in Atherosclerosis and Endothelial Dysfunction
Clinical and Applied Thrombosis/Hemostasis, October 1, 2007; 13(4): 384 - 390.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
F. Bilora, E. Zanon, F. Petrobelli, M. Cavraro, P. Prandoni, A. Pagnan, and A. Girolami
Does Hemophilia Protect Against Atherosclerosis? A Case-Control Study
Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 193 - 198.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Khallou-Laschet, G. Caligiuri, E. Tupin, A.-T. Gaston, B. Poirier, E. Groyer, D. Urbain, S. Maisnier-Patin, R. Sarkar, S.V. Kaveri, et al.
Role of the Intrinsic Coagulation Pathway in Atherogenesis Assessed in Hemophilic Apolipoprotein E Knockout Mice
Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): e123 - e126.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Sramek, P. Bucciarelli, A.B. Federici, P.M. Mannucci, V. De Rosa, G. Castaman, M. Morfini, M.G. Mazzucconi, A. Rocino, M. Schiavoni, et al.
Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis: Results From a Multicenter Study in 47 Patients
Circulation, February 17, 2004; 109(6): 740 - 744.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev, October 1, 2003; 83(4): 1069 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Weng, L. Zemany, K. N. Standley, D. V. Novack, M. La Regina, C. Bernal-Mizrachi, T. Coleman, and C. F. Semenkovich
{beta}3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice
PNAS, May 27, 2003; 100(11): 6730 - 6735.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
O. Shpilberg, I. Rabi, K. Schiller, R. Walden, D. Harats, K.S. Tyrrell, B. Coller, and U. Seligsohn
Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein {alpha}IIb{beta}3 (GPIIb/IIIa) and {alpha}v{beta}3 Receptors Are Not Protected From Atherosclerosis
Circulation, March 5, 2002; 105(9): 1044 - 1048.
[Abstract] [Full Text] [PDF]